Viewing Study NCT00001761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:55 PM
Ignite Modification Date: 2026-02-03 @ 6:10 AM
Study NCT ID: NCT00001761
Status: COMPLETED
Last Update Posted: 2008-03-04
First Post: 1999-11-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Vasculitis View
None Wegener's Granulomatosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Autoimmunity View
None Cytokine View
None Inflammation View
None Interleukin View
None Vasculitis View
None Wegener's Granulomatosis View